In the past decade(s) the pharma industry has experienced an innovation gap crisis characterized by relatively flat growth rate in new drug approval rates and a steady growth of 2.5X in cost.
Read More
In the Name of Democracy
On many occasions we hear institutions and nation-states wage conflict with others in the name of democracy. The primary objective to an institution’s leverage of the “democratic cause” is to garner support from its citizens. However any citizen who takes credence to this “call to arms” indiscriminately does so at the risk
Read More